pharma · Anal Neoplasm · Lassa Fever · INO
INOVIO Pharmaceuticals
INOVIO PHARMACEUTICALS, INC.
INOVIO Pharmaceuticals clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO · NYSE Ticker
Company details
- Status
- Public
- HQ
- 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
- Employees
- 203
- Programs
- 46
- Drugs
- 8
- Patents
- 75
INOVIO Pharmaceuticals projects
2 ClinicalTrials.gov programs sponsored by INOVIO Pharmaceuticals.
INOVIO Pharmaceuticals has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does INOVIO Pharmaceuticals have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.